Semnur Pharmaceuticals, Inc. (SMNRW) — 10-Q Filings
All 10-Q filings from Semnur Pharmaceuticals, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Semnur's Q3 Loss Explodes Post-Merger Amid Soaring G&A Costs
— Nov 12, 2025 Risk: high
Semnur Pharmaceuticals, Inc. (SMNRW) completed a reverse recapitalization business combination on September 22, 2025, with Denali Capital Acquisition Corp., res -
Denali Capital Acquisition Corp. Files Q2 2025 10-Q
— Aug 15, 2025 Risk: low
Denali Capital Acquisition Corp. filed its 10-Q for the quarterly period ended June 30, 2025. The company, incorporated in the Cayman Islands with its principal -
Denali Capital Acquisition Corp. Files Q1 2025 10-Q
— May 16, 2025 Risk: low
Denali Capital Acquisition Corp. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in the Cayman Islands with its principa -
Denali Capital Acquisition Corp. Files Q3 2024 10-Q
— Nov 19, 2024 Risk: medium
Denali Capital Acquisition Corp. filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in the Cayman Islands with its prin -
Denali Capital Acquisition Corp. Files Q2 2024 10-Q
— Aug 19, 2024 Risk: medium
Denali Capital Acquisition Corp. filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in the Cayman Islands, is a blank check -
Denali Capital Acquisition Corp. Files Q1 2024 10-Q
— May 22, 2024 Risk: low
Denali Capital Acquisition Corp. filed its 10-Q for the quarterly period ended March 31, 2024. The company, incorporated in the Cayman Islands, is a blank check
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX